Important Safety Information & Warnings

This module covers the critical safety information, warnings, and precautions for 0.9% Sodium Chloride Injection, USP as required by the FDA prescribing information. All Bridge clinicians must be familiar with these warnings.

Hypersensitivity Reactions: Reactions including hypotension, pyrexia, tremor, chills, urticaria, rash, and pruritus have been reported. If any signs develop — including tachycardia, chest pain, dyspnea, or flushing — stop the infusion immediately and institute appropriate therapeutic countermeasures.

Electrolyte Imbalances: Fluid Overload — IV sodium chloride can cause overhydration, hypervolemia, and pulmonary congestion depending on volume, rate, and patient condition. Avoid in patients at risk for fluid overload. Hyponatremia — can lead to encephalopathy with headache, nausea, seizures, lethargy, and vomiting. Monitor serum sodium levels. Hypernatremia — risk increases in patients with hyperaldosteronism, heart failure, liver disease, renal disease, or pre-eclampsia.

Special Populations: Pediatric patients may have impaired ability to regulate fluids and electrolytes — closely monitor plasma electrolytes. Geriatric patients are at increased risk of electrolyte imbalances and may require dose adjustment. Pregnancy — use only if benefit justifies risk. Nursing mothers — exercise caution.

Drug Interactions: Corticosteroids and corticotropin increase risk of sodium and fluid retention. Lithium clearance may be increased. Diuretics, certain antiepileptics, and psychotropic medications increase hyponatremia risk. Monitor serum electrolytes when co-administering with any of these drug classes.